title: Use of monoclonal antibodies in vivo as a therapeutic strategy for alloimmune or autoimmune reactivity: the Besançon experience.
authors: Bone Marrow Transplantation Unit, Hospital Jean Minjoz, Besançon, France.
authors: P
authors: P
authors: Herve
authors: E
authors: E
authors: Racadot
authors: D
authors: D
authors: Wendling
authors: L
authors: L
authors: Rumbach
authors: P
authors: P
authors: Tiberghien
authors: J Y
authors: JY
authors: Cahn
authors: M
authors: M
authors: Flesch
authors: J
authors: J
authors: Wijdenes
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000628:therapy; D001327:Autoimmune Diseases / Q000628:therapy*; D016026:Bone Marrow Transplantation; D016207:Cytokines / Q000276:immunology; D006086:Graft vs Host Disease / Q000628:therapy*; D006801:Humans; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000628:therapy; D010865:Pilot Projects; D015375:Receptors, Interleukin-2 / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D016207:Cytokines; D015375:Receptors, Interleukin-2